Research led by the University of Birmingham has discovered an important first step in the pathway for developing personalised medicine for the treatment of head and neck cancer.
Research led by the University of Birmingham has found important new ways that the BRCA1 gene functions, which could help expand our understanding of the development of ovarian and breast cancers.
Dr Aga Gambus, a Senior Lecturer in the Institute of Cancer and Genomic Sciences, has been awarded a Wellcome Investigator Award to investigate the process of replication machinery disassembly.
National Health Service (NHS) England reduced post-operative deaths by 37.2% following the introduction of globally recognised surgical guidelines.
University of Birmingham women's cancer expert Professor Sudha Sundar has been named as one of the most influential people in UK-India relations.
Dr Marco Saponaro, Birmingham Fellow in the Institute of Cancer and Genomic Sciences, has been awarded a BBSRC Responsive Mode grant.
The Institute of Cancer and Genomic Sciences recently appointed Steve Smerdon as Professor of Structural Biology. He joins Birmingham from The Francis Crick Institute, London.
Professor Ian Tomlinson, Director of the Institute of Cancer and Genomic Sciences, has been awarded a Wellcome Trust Investigator Award in Science of £2 million for research into different types of IDH mutation.
Significant funding of over £3.8 million has been awarded to the Cancer Research UK (CRUK) Birmingham Centre, based at the University of Birmingham, to develop its clinical academic training programme.
Scientists at the University of Birmingham and Newcastle University have teamed up to develop new ways of treating different classes of Acute Myeloid Leukaemia (AML) carrying specific gene mutations.